Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
The European Medicines Agency recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer .. The drug is intended for adults and adolescents with advanced solid tumors and adults with locally advanced or metastatic NSCLC .
Repotrectinib was recommended as monotherapy for the treatment of adult and pediatric patients 12 years of age and older with advanced solid tumors expressing agene fusion and have received a prior NTRK inhibitor or have not received a prior NTRK inhibitor but have limited or exhausted other treatment options.
The committee recognized that the drug fulfilled an unmet need, but the authorization was granted on the condition that the manufacturer provides additional data at a later date.) exon 19 deletions or exon 21 L858R substitution mutations.Available as 80 mg and 240 mg film-coated tablets, lazertinib should be prescribed by physicians experienced in the use of anticancer medicinal products, the committee said.
Nsclc Lung Cancer Lung Carcinoma Cancer Of The Lung Drug Legislation Drug Registries Drug Registry Drug Regulation Drug Development Drug Discovery Drug Pipeline Drug Development Pipeline Drug/Treatment Safety Drug Safety Treatment Safety Dentistry Oral Health Oral Medicine Dental Health Dental Oral Healthcare Oral Health Care Cancer Malignant Neoplasia
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Scientists use microcellular drones to deliver lung cancer-killing drugsExtracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.
Read more »
Scripps Cancer Center to Host Free Lung Cancer Screening Event Nov. 8Scripps Cancer Center invites local residents to learn about lung cancer screening at a free educational event on Friday, Nov. 8 from 9 a.m. to 12 noon at Scripps Medical Center Jefferson in Oceanside.
Read more »
Two close friends, united by cancer, co-chair ‘Shuck Cancer’ to raise funds and awarenessHoustonians Nora Jarrard and Katie Tsuru, co-chairs of 'Shuck Cancer,' the annual fundraiser supporting the American Cancer Society, chat with Houston Life's Derrick Shore about the important research and prevention efforts underway and the deeply personal reasons this cause is so important to each of them.
Read more »
Study links methylmalonic acid to weakening of immune cells in lung cancerA new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through which aging may promote lung cancer progression.
Read more »
Detecting evidence of lung cancer in exhaled breathExhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors provide early diagnoses -- and improve patients' prospects.
Read more »
Climate Change May Be Linked to Lung Cancer in Never-SmokersAn American Cancer Society expert urges clinicians to advocate for action in the healthcare industry to help combat climate change and its effects on lung cancer incidence.
Read more »